|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 359.07 USD | -0.32% |
|
+8.56% | -2.66% |
| Capitalization | 7.98TCr 6.8TCr 6.35TCr 5.97TCr 11TCr 7,22500Cr 12TCr 74TCr 29TCr 3,40600Cr 30TCr 29TCr 12,43200Cr | P/E ratio 2025 * |
14.2x | P/E ratio 2026 * | 14.7x |
|---|---|---|---|---|---|
| Enterprise value | 10TCr 8.73TCr 8.16TCr 7.67TCr 14TCr 9,28300Cr 15TCr 95TCr 37TCr 4,37700Cr 38TCr 38TCr 15,97400Cr | EV / Sales 2025 * |
0.52x | EV / Sales 2026 * | 0.5x |
| Free-Float |
99.81% | Yield 2025 * |
1.86% | Yield 2026 * | 1.96% |
Last Transcript: Elevance Health, Inc.
| 1 day | -0.32% | ||
| 1 week | +8.56% | ||
| Current month | +6.15% | ||
| 1 month | +9.38% | ||
| 3 months | +15.18% | ||
| 6 months | -6.63% | ||
| Current year | -2.66% |
| 1 week | 323.04 |  | 363.42 |
| 1 month | 311.88 | | 363.42 |
| Current year | 273.71 | | 458.75 |
| 1 year | 273.71 | | 458.75 |
| 3 years | 273.71 | | 567.26 |
| 5 years | 273.71 | | 567.26 |
| 10 years | 114.85 | | 567.26 |
| Manager | Title | Age | Since |
|---|---|---|---|
Gail Boudreaux
CEO | Chief Executive Officer | 64 | 20/11/2017 |
Mark Kaye
DFI | Director of Finance/CFO | 46 | 01/11/2023 |
Dustin Wilcox
CTO | Chief Tech/Sci/R&D Officer | - | 01/08/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Ramiro Peru
CHM | Chairman | 69 | - |
Robert Dixon
BRD | Director/Board Member | 69 | 01/07/2011 |
Lewis Hay
BRD | Director/Board Member | 69 | 01/07/2013 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 3.22% | 26 M€ | +12.27% | - |
| 2.07% | 5 M€ | 0.00% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.32% | +8.56% | -5.86% | -30.86% | 7.98TCr | |
| +1.52% | +3.30% | -34.32% | -36.49% | 31TCr | |
| +0.90% | +3.49% | -2.54% | -16.82% | 7.34TCr | |
| +0.74% | +4.11% | -2.07% | -48.68% | 3.23TCr | |
| +0.96% | +6.55% | -31.25% | -50.91% | 2.01TCr | |
| +0.96% | +10.96% | -44.39% | -51.68% | 866.09Cr | |
| -0.26% | -0.97% | +69.08% | +59.87% | 387.38Cr | |
| +2.69% | +11.20% | +82.82% | -15.93% | 230.27Cr | |
| -1.82% | +4.65% | -13.18% | +143.24% | 139.5Cr | |
| -2.25% | -0.17% | -24.41% | - | 39Cr | |
| Average | +0.31% | +5.17% | -0.61% | -5.36% | 5.32TCr | |
| Weighted average by Cap. | +1.06% | +4.42% | -22.43% | -33.20% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 20TCr 17TCr 16TCr 15TCr 27TCr 17,93200Cr 30TCr 1,83300Cr 71TCr 8,45400Cr 74TCr 73TCr 30,85500Cr | 20TCr 17TCr 16TCr 15TCr 28TCr 18,50300Cr 31TCr 1,89200Cr 73TCr 8,72300Cr 77TCr 75TCr 31,83700Cr |
| Net income | 569.62Cr 485.23Cr 453.21Cr 426.08Cr 784.19Cr 52TCr 856.97Cr 5.27TCr 2.05TCr 24TCr 2.14TCr 2.09TCr 89TCr | 535.21Cr 455.92Cr 425.83Cr 400.34Cr 736.82Cr 48TCr 805.21Cr 4.95TCr 1.92TCr 23TCr 2.01TCr 1.97TCr 83TCr |
| Net Debt | 2.27TCr 1.94TCr 1.81TCr 1.7TCr 3.13TCr 2,05800Cr 3.42TCr 21TCr 8.17TCr 97TCr 8.53TCr 8.35TCr 3,54100Cr | 2.31TCr 1.97TCr 1.84TCr 1.73TCr 3.18TCr 2,09000Cr 3.47TCr 21TCr 8.3TCr 99TCr 8.66TCr 8.48TCr 3,59600Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/25/12 | 359.07 $ | -0.32% | 20,90,647 |
| 11/25/11 | 360.22 $ | +5.62% | 29,90,681 |
| 10/25/10 | 341.04 $ | +3.40% | 13,18,184 |
| 09/25/09 | 329.81 $ | -0.24% | 12,96,178 |
| 08/25/08 | 330.61 $ | -0.04% | 17,65,482 |
Delayed Quote Nyse, December 13, 2025 at 02:30 am IST
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ELV Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition